Cargando…
CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells
CRISPR-Cas9 genome engineering can be used to functionally investigate the complex mechanisms of immune system regulation. Decades of work have aimed to genetically reprogram innate immunity, but current approaches are inefficient or nonspecific, limiting their use. Here, we detail an optimized stra...
Autores principales: | Hildreth, Andrew D., Riggan, Luke, O’Sullivan, Timothy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756923/ https://www.ncbi.nlm.nih.gov/pubmed/33377009 http://dx.doi.org/10.1016/j.xpro.2020.100113 |
Ejemplares similares
-
Genome editing in Penicillium funiculosum using in vitro assembled CRISPR-Cas9 ribonucleoprotein complexes
por: Sinha, Tulika, et al.
Publicado: (2022) -
CRISPR-Cas12a ribonucleoprotein-mediated gene editing in the plant pathogenic fungus Magnaporthe oryzae
por: Huang, Jun, et al.
Publicado: (2021) -
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021) -
CRISPR/Cas9 ribonucleoprotein-mediated knockin generation in hTERT-RPE1 cells
por: Ghetti, Sabrina, et al.
Publicado: (2021) -
Multiplexed CRISPR gene editing in primary human islet cells with Cas9 ribonucleoprotein
por: Bevacqua, Romina J., et al.
Publicado: (2023)